30218 Federal Register / Vol. 66, No. 108 / Tuesday, June 5, 2001 / Notices

and issues a periodic newsletter, and is

the focal point for conference and

meeting planning activities for the

Bureau.

6. Division of State Systems (DSS)

reviews, assesses, and inspects the

planning, design and operation of State

management information systems and

approves advanced planning documents

for automated data systems. The

Division provides leadership for the

provision of technical assistance to

States on information systems projects

and advances the use of computer

technology in the administration of

child welfare and social services

programs by States. The Division

reviews, analyzes, and approves/

disapproves State requests for federal

financial participation for automated

systems development and activities

which support child welfare programs,

including foster care and adoption. It

provides assistance to States in

developing or modifying automation

plans to conform to federal

requirements. It monitors approved

State system development activities and

conducts periodic reviews to assure

State compliance with regulatory

requirements applicable to automated

systems supported by Federal financial

participation. It provides guidance to

States on functional requirements for

these automated information systems. It

promotes interstate transfer of existing

automated systems and provides

assistance and guidance to improve

ACYF’s programs through the use of

automated systems.

Dated: May 30, 2001.

James A. Harrell,

Acting Commissioner, Administration on

Children, Youth and Families.

[FR Doc. 01–14058 Filed 6–4–01; 8:45 am]

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substances and

Disease Registry

Medical Testing Associated With

Exposure to Asbestos; Meeting

The Agency for Toxic Substances and

Disease Registry (ATSDR), Division of

Health Studies (DHS) announces the

following meeting:

Name: Medical Testing Associated with

Exposure to Asbestos.

Times and Dates: 10:00 a.m.–6:00 p.m.,

June 18, 2001; 8:30 a.m.–5:00 p.m., June 19,

2001.

Place: Sheraton Buckhead Hotel; 3405

Lenox Road; Atlanta, GA 30326.

Status: Open to the public, limited only by

the space available.

Purpose: This is a working group meeting

to discuss issues related to initial and followup testing of persons with environmental and

historic occupational exposure to

asbestoform materials from vermiculite

mined in Libby, MT.

Matters To Be Discussed: The agenda will

include a discussion on the routes and

duration of exposure to asbestoform materials

through both historic environmental and

occupational routes; commonly conducted

screening tests; frequency and periodicity of

follow-up testing; use of standard testing

procedures; and testing of special and/or

sensitive populations.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Jeffrey A. Lybarger, M.D., director, Division

of Health Studies, ATSDR, 1600 Clifton

Road, NE, m/s E31, Atlanta, Georgia 30333.

Telephone 404/639–6200.

The Director, Management Analysis and

Services office has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: May 24, 2001.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 01–14050 Filed 6–4–01; 8:45 am]

BILLING CODE 4163–70–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 01N–0069]

Agency Information Collection

Activities; Submission for OMB

Review; Comment Request;

Information From U.S. Processors That

Export to the European Community

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that the proposed collection of

information listed below has been

submitted to the Office of Management

and Budget (OMB) for review and

clearance under the Paperwork

Reduction Act of 1995.

DATES: Submit written comments on the

collection of information by July 5,

2001.

ADDRESSES: Submit written comments

on the collection of information to the

Office of Information and Regulatory

Affairs, OMB, New Executive Office

Bldg., 725 17th St. NW., rm. 10235,

Washington, DC 20503, Attn: Wendy

Taylor, Desk Officer for FDA.

FOR FURTHER INFORMATION CONTACT:

Peggy Schlosburg, Office of Information

Resources Management (HFA–250),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–827–1223.

SUPPLEMENTARY INFORMATION: In

compliance with 44 U.S.C. 3507, FDA

has submitted the following proposed

collection of information to OMB for

review and clearance.

Request for Information From U.S.

Processors That Export to the European

Community (OMB Control Number

0910–0320)—Extension

The European Community (EC) is a

group of 15 European countries that

have agreed to harmonize their

commodity requirements to facilitate

commerce among member States. EC

legislation for intra-EC trade has been

extended to trade with non-EC

countries, including the United States.

For certain food products, including

those listed below in this document, EC

legislation requires assurances from the

responsible authority of the country of

origin that the processor of the food is

in compliance with applicable

regulatory requirements.

With the assistance of trade

associations and State authorities, FDA

requests information from processors

that export certain animal-derived

products (e.g., shell eggs, dairy

products, game meat, game meat

products, animal casings, and gelatin) to

EC. FDA uses the information to

maintain lists of processors that have

demonstrated current compliance with

U.S. requirements and provides the lists

to EC quarterly. Inclusion on the list is

voluntary. EC member countries refer to

the lists at ports of entry to verify that

products offered for importation to EC

from the United States are from

processors that meet U.S. regulatory

requirements. Products processed by

firms not on the list are subject to

detention and possible refusal at the

port. FDA requests the following

information from each processor:

1. Business name and address;

2. Name and telephone number of

person designated as business contact;

3. Lists of products presently being

shipped to EC and those intended to be

shipped in the next 6 months;

4. Name and address of

manufacturing plants for each product;

5. Names and affiliations of any

Federal, State, or local governmental

agencies that inspect the plant,

government-assigned plant identifier,

such as plant number, and last date of

inspection; and

Federal Register / Vol. 66, No. 108 / Tuesday, June 5, 2001 / Notices 30219

6. Assurance that the firm or

individual representing the firm and

submitting a certificate for signature to

FDA is aware of and knows that they are

subject to the provisions of section 1001

of Title 18, United States Code. This law

provides that it is a criminal offense to

knowingly and willfully make a false

statement or alter or counterfeit

documents in a matter within the

jurisdiction of a U.S. agency.

In the Federal Register of February

28, 2001 (66 FR 12802), the agency

requested comments on the proposed

collection of information. One comment

was received. In this comment there

were two concerns regarding burden.

The first was that States may incur more

than ‘‘information’’ burden. The impact

on a few States has been to retrieve

inspection reports from FDA contracted

inspections or from a State inspection.

The second concern was that FDA

‘‘assumed no operating or maintenance

costs’’. The burden on a company for

placement on an EC required list is only

the initial information asked for in the

Federal Register notice. A company

may inquire about the status during the

review process for placement on the list

but this is of their choosing.

FDA estimates the burden of this

collection of information as follows:

TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1

Products No. of

Respondents

Annual Frequency

per Response

Total Annual

Responses

Hours per

Response Total Hours

Shell eggs 10 1 10 0.25 2.5

Dairy 100 1 100 0.25 25

Game meat and meat products 10 1 10 0.25 2.5

Animal casings 15 1 15 0.25 3.75

Gelatin 6 1 6 0.25 1.5

Total 35.25

1There are no capital costs or operating and maintenance costs associated with this collection of information.

The estimated number of respondents

is based on the volume of exports and

responses received to date. The

estimated number of yearly responses

has decreased from the estimate in

FDA’s previous notice seeking comment

for this collection of information (63 FR

29738, June 1, 1998) because the actual

number of responses has been

decreasing. Companies do not need to

reapply unless they have a compliance

problem. An estimate for processors that

export gelatin also has been added

because these processors are now being

included in the listing process.

TABLE 2.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1

Respondents No. of Recordkeepers

Annual Frequency of

Recordkeeping

Total Annual

Records

Hours per Recordkeeper Total Hours

Trade association 15 1 15 8 120

State 50 1 50 8 400

Total 520

1There are no capital costs or operating and maintenance costs associated with this collection of information.

The burden estimated for the trade

associations assumes the trade

associations will disseminate FDA’s

information request through mass

mailings to their membership or publish

it in their trade magazine or newsletter.

The burden estimated for State

authorities assumes dissemination of

information to the processors or

dissemination of information about

processors to FDA.

Dated: May 29, 2001.

Margaret M. Dotzel,

Associate Commissioner for Policy.

[FR Doc. 01–13985 Filed 6–4–01; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Indian Health Service

Indians Into Medicine Program;

Correction

AGENCY: Indian Health Services, HHS.

ACTION: Notice; correction.

SUMMARY: The Indian Health Service

published a document in the Federal

Register on May 18, 2001, concerning

an application deadline of June 1, 2001,

for the Indians Into Medicine Program.

The document contained an incorrect

deadline date.

FOR FURTHER INFORMATION CONTACT: Ms.

Jacqueline Santiago, Chief, Loan

Repayment Branch, Division of Health

Professions Support, Indian Health

Service, 12300 Twinbrook Parkway,

Suite 100A, Rockville, MD 20852,

Telephone 301–443–3396. (This is not a

toll-free number.)

Correction

In the Federal Register of May 18,

2001, in FR Doc. 01–12529, on page

27665, in the third column, correct the

DATES caption to read:

DATES: A. Application Receipt Date—An

original and two (2) copies of the

completed grant application must be

submitted with all required

documentation to the Grants

Management Branch, Division of

Acquisition and Grants Management,

Twinbrook Building, Suite 100, 12300

Twinbrook Parkway, Rockville,

Maryland 20852, by close of business

June 18, 2001.

Dated: March 29, 2001.

Michel E. Lincoln,

Deputy Director.

[FR Doc. 01–13987 Filed 6–4–01; 8:45 am]

BILLING CODE 4160–16–M